NAS:BBIO (USA) Also Trade In: Germany

BridgeBio Pharma Inc $ 66.17 -5.74 (-7.98%)

Volume:
827,375
Avg Vol (1m):
1,160,526
Market Cap $:
9.86 Bil
Enterprise Value $:
9.79 Bil
PE Ratio:
0.00
PB Ratio:
135.87
Warning! GuruFocus has detected 2 Severe warning signs with BBIO. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

Financial Strength

4/10
Current Vs Industry Vs History
Cash-To-Debt 1.23
Equity-to-Asset 0.08
Debt-to-Equity 8.56
Debt-to-EBITDA -1.06
N/A
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.74
DISTRESS
GREY
SAFE
Beneish M-Score -5.75
Not Manipulator
Manipulator
WACC vs ROIC
ROIC -590.29 %
WACC 7.58 %

Profitability Rank

Current Vs Industry Vs History
Operating Margin % -5751.99
Net Margin % -5439.74
ROE % -175.75
ROA % -55.84
ROC (Joel Greenblatt) % -1971.01
3-Year EBITDA Growth Rate -102.5
N/A
3-Year EPS without NRI Growth Rate -86.4
N/A

Valuation Rank

Current Vs Industry Vs History
PB Ratio 135.87
PS Ratio 945.29
EV-to-EBIT -20.89
N/A
EV-to-EBITDA -20.89
N/A
EV-to-Revenue 1187.23
Current Ratio 6.72
Quick Ratio 6.72

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.5
N/A

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 135.04
Earnings Yield (Greenblatt) % -4.78